Abstract:Idiopathic Parkinson’s disease (IPD) is characterised by a triad of motor symptoms, namely bradykinesia, rigidity and resting tremor, although cognitive impairment is a common feature of the disease and has been accepted as one of the strong predictors of quality of life in such patients. Neuropsychological testing in Parkinson’s disease often reveals a pattern of cognitive impairment similar to that observed in patients with frontal lobe lesions, although clear differences between the two groups have also often been reported. This apparent inconsistency in the literature may reflect heterogeneity among different groups of patients with Parkinson’s disease, although to date this possibility has not been formally addressed. In this study, two groups of patients with Parkinson’s disease were assessed on a novel verbal memory task, which allowed different aspects of working memory function such as maintenance, retrieval and manipulation to be tested within the same general paradigm. The two groups were selected according to either good or bad performance on a ‘standard’, visuospatial test of executive function (The Tower of London Task), but were well matched on all other demographic and cognitive measures tested. The sub-group of Parkinson’s disease patients with Tower of London defined executive deficit were specifically impaired at manipulating information within verbal working memory, both compared to controls and to the group of patients with no predefined executive impairments. In contrast, the three groups did not differ in their ability to maintain or retrieve information within verbal working memory. Given the known preferential role of the dorsolateral frontal cortex in higher executive functions, (including both planning and the manipulation of information within working memory), these results suggest that, in a subset of Parkinson’s disease patients, it is the frontostriatal circuitry involving this region which is primarily affected, while other components of this circuitry may be relatively spared. The results also suggest that performance on the Tower of London task may prove to be a useful discriminant variable in defining the nature of cognitive heterogeneity in Parkinson’s disease.

Dopamine-dependent Frontostriatal Planning Deficits in Early Parkinson's Disease.

Fronto-striatal Cognitive Deficits at Different Stages of Parkinson's Disease.

Planning and Spatial Working Memory in Parkinson's Disease.

Spatial and Non-Spatial Working Memory at Different Stages of Parkinson's Disease

Planning and Spatial Working Memory Following Frontal Lobe Lesions in Man

Dopaminergic Modulation of High-Level Cognition in Parkinson'S Disease: the Role of the Prefrontal Cortex Revealed by Pet

Lateralisation of Striatal Function: Evidence from 18F-Dopa PET in Parkinson's Disease.

Impaired Planning but Intact Decision Making in Early Huntington’s Disease: Implications for Specific Fronto-Striatal Pathology

Monoaminergic-Dependent Cognitive Functions of the Prefrontal Cortex in Monkey and Man

A novel method to assess motor planning deficits in patients with Parkinson's disease and mild cognitive impairment

Visuospatial Memory Deficits at Different Stages of Parkinson's Disease

L-Dopa Withdrawal in Parkinson's Disease Selectively Impairs Cognitive Performance in Tests Sensitive to Frontal Lobe Dysfunction

Dopaminergic Basis for Deficits in Working Memory but Not Attentional Set-Shifting in Parkinson's Disease

Cognitive Deficits in Progressive Supranuclear Palsy, Parkinson's Disease, and Multiple System Atrophy in Tests Sensitive to Frontal Lobe Dysfunction.

Contrasting Mechanisms of Impaired Attentional Set-Shifting in Patients with Frontal Lobe Damage or Parkinson's Disease.

The Effect of Dopamine Replacement Therapy on Cortical Structure in Parkinson's Disease.

Cognitive Impairments in Early Parkinson's Disease Are Accompanied by Reductions in Activity in Frontostriatal Neural Circuitry.

Enhanced or Impaired Cognitive Function in Parkinson's Disease As a Function of Dopaminergic Medication and Task Demands.

Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function

Parkinson's disease and dopaminergic therapy—differential effects on movement, reward and cognition

Using Executive Heterogeneity to Explore the Nature of Working Memory Deficits in Parkinson'S Disease